Clinical Trial Manager & Senior Clinical Trial Manager

in a biotech company focused on the discovery, design and development of innovative peptide-based medicines

In Zealand Pharma we are looking for several Clinical trial Managers/Senior Clinical Trial Managers to join our clinical trial teams as we pursue new and exciting therapeutic areas and optimized ways of working. We are looking for clinical trial managers with a least 2 years of practical experience from working with clinical trials as a Clinical Research Associate, Clinical Trial Manager or similar. If this sounds like you, and you are ready to take on a broad area of responsibilities with an independent attitude, you are a match for us.​

Our Clinical operations department consist of around 16 engaged and professional colleagues. We work as one team and value an informal atmosphere with focus on knowledge sharing and excellence. We are responsible for driving forward the clinical project portfolio by setting up, overseeing, and reporting clinical trials in collaboration with CROs. Together with your Zealand Pharma colleagues and CRO team you will be responsible for delivering well conducted clinical trials within agreed timelines, quality, and budget.

In your role as a Clinical Trial Manager, you will play a crucial role in facilitating effective collaboration among essential stakeholders involved in the execution of clinical trials. This includes close collaboration with a Clinical Research Organization (CROs) and internal stakeholders to ensure successful start-up, conduct, and closure of clinical trials.

Your responsibilities extend from the initial planning phase to the reporting stage of clinical trials. In this capacity, you will lead the clinical trial team to achieve outcomes that significantly influence the successful execution of clinical trials. the role involves the coordination and assurance of trial deliverables from key partners, both within and outside the organization. Additionally, you will oversee the performance of the Clinical Research Organization (CRO), ensuring contractual agreements are in place and upheld.

Candidate profile
The successful candidate will have:

Bonding to innovate ​

Our employees are fundamental to our success, and we continue to be able to attract and retain people with vast experience and talent. We have a unique culture, characterized by excellent teamwork and strong engagement across the organization.​

Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other.​

We bond as a result of our entrepreneurial culture where our people are encouraged to pursue their ideas and turn them into reality. We are curious about each other’s knowledge and expertise. ​

We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Zealand Pharma is a place where everyone is heard and contributes to the success, we all want to experience.​

The Zealand Pharma DNA builds on four values: (1) We are bold, (2) We empower people, (3) We work as one team, and (4) We can be trusted.​

Let’s bond and be bold ​

We offer a combined compensation package which includes a base salary, pension, bonus, and a possibility to join our employee share program. We care about our employees’ well-being and offer health insurance, use of massage, fitness, and a range of social clubs and activities

To find out more about working at Zealand, visit

Interested? Please apply no later than February 29, 2024, or as soon as possible. The applications will be reviewed as they come in.

For further information, please contact Rikke Ottesen at +45 5060 3813 or

About Zealand Pharma A/S

Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Additionally, the portfolio includes clinical license collaboration with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals. Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit or bond with us through LinkedIn or Twitter @ZealandPharma.